Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01156194
Other study ID # ArBel.2010
Secondary ID
Status Completed
Phase Phase 3
First received July 1, 2010
Last updated February 19, 2012
Start date January 2011
Est. completion date January 2012

Study information

Verified date February 2012
Source Shaare Zedek Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel, Ministry of Health:Pharmacy Division
Study type Interventional

Clinical Trial Summary

The homeopathic remedy consisting of Arnica and Bellis perennis have been shown in a previous pilot study (n=33) to reduce blood loss during the third stage of delivery, when compared with placebo treatment. The purpose of this study is to repeat the previous methodology, this time on a larger population.

210 parturients will be randomized to one of three groups: Arnica montana C6 and Bellis perennis C6 (n=70), Arnica montana C30 and Bellis perennis C30 (n=70), or double placebo (n=70).


Recruitment information / eligibility

Status Completed
Enrollment 210
Est. completion date January 2012
Est. primary completion date January 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 35 Years
Eligibility Inclusion Criteria:

- healthy women in 3rd stage of labor

- age 20-35

- second to fifth gestation

- spontaneous PV delivery

- term delivery (37-42nd weeks)

Exclusion Criteria:

- scarred uterus

- multifetal pregnancy

- history of bleeding problems

- caesarian section delivery

- chorioamnionitis

- pregnancy-induced hypertension

- gestational diabetes mellitus

- polyhydramnios, premature rupture of membrane

- suspected macrosomy/SGA

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Homeopathy 1
Arnica montana C6 and Bellis perennis C6
Homeopathy 2
Arnica montana C30 and Bellis perennis C30
Placebo
globule identical to true homeopathy comparators

Locations

Country Name City State
Israel Maternity Ward, Shaare Zedek Medical Center Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Shaare Zedek Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hemoglobin levels at 2d postpartum 48h Yes
Secondary incidence of endometritis 7d Yes
Secondary time to extrusion of placenta following birth 24h Yes
Secondary duration of lochiae secretion 7days No
Secondary duration of third stage of labor 24h Yes
Secondary assessment of quality-of-life parameters 7 days No
Secondary assess toxic effects of the homeopathic remedies 7 days Yes
Secondary serum cortisol levels within 12h postpartum No
Secondary state of perineum postpartum 48h Yes
See also
  Status Clinical Trial Phase
Completed NCT00826735 - The Effect of Guided Imagery on the Third Stage of Labor N/A
Completed NCT04463485 - Impact of Umbilical Cord Clamping Time on Infant Anemia N/A